Biofuels Maker Collapsing on Secondary Offering (GEVO, DD, BP, CDXS, AMRS, SZYM, KIOR, BG)

Photo of Paul Ausick
By Paul Ausick Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Chemical and biofuels maker Gevo Inc. (NASDAQ: GEVO) announced this morning that it “intends to offer and sell, subject to market and other conditions, shares of its common stock and convertible senior notes due 2022.” The company did not specify any numbers, but did say how the net proceeds would be used:

[Gevo will use the proceeds] to repay a portion of its outstanding long-term debt obligations, to fund the cash consideration payable to complete the retrofit of its Luverne, Minn. plant, and to partially fund the Redfield Energy retrofit. To the extent that the net proceeds are not used for these purposes, the Company intends to use them to fund working capital and for other general corporate purposes.

Shares are getting pummeled on the news, down about -20%. Just last week Gevo shares soared about 35% following a favorable ruling in a patent dispute with Butamax Advanced Biofuels LLC, a joint venture of E.I. du Pont de Nemours & Co. (NYSE: DD) and BP plc (NYSE: BP).

At one time biofuel makers had replaced ethanol and solar panel makers as the “next big thing.” Codexis Inc. (NASDAQ: CDXS), Amyris Inc. (NASDAQ: AMRS), Solazyme Inc. (NASDAQ: SZYM), and KiOr Corp. (NASDAQ: KIOR). Today all trade at least -50% lower than their 52-week highs, and some have already gotten into the boutique chemicals business, while a couple of others are trying.

Gevo is converting existing ethanol plants into biorefineries “to make renewable building block products for the chemical and fuel industries.” Isobutanol, the company’s drop-in substitute for petroleum-based fuels. KiOR plans to have its first cellulosic fuels plant operating by the end of this year. Codexis is focused on the cosmetics business, Amyris is working a drop-in substitute for jet fuel, and Solazyme recently broke ground on a renewable oil plant in Brazil that the company owns in a joint venture with food giant Bunge Ltd. (NYSE: BG).

It’s not that these companies aren’t doing anything. The problem is that any significant volumes of new fuel products are still years away. The US Congress in 2007 mandated that 500 million gallons of cellulosic ethanol be added to the nation’s fuel supply by 2013. The revised mandate for 2012 calls for just 8.5 million gallons and there’s not much likelihood that that total will be reached. Even 500 million gallons is barely equivalent to 12 million barrels of crude oil, less than one day’s US consumption of crude.

Gevo’s shares are down -20% at $7.01 in a 52-week range of $4.84-$18.75.

Paul Ausick

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618